1085 related articles for article (PubMed ID: 22633949)
1. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
Nithianantharajah J; Hannan AJ
Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
[TBL] [Abstract][Full Text] [Related]
2. Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.
Murmu RP; Li W; Szepesi Z; Li JY
J Neurosci; 2015 Jan; 35(1):287-98. PubMed ID: 25568121
[TBL] [Abstract][Full Text] [Related]
3. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
[TBL] [Abstract][Full Text] [Related]
4. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
van Dellen A; Grote HE; Hannan AJ
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
[TBL] [Abstract][Full Text] [Related]
6. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
[TBL] [Abstract][Full Text] [Related]
7. Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease.
Cummings DM; Milnerwood AJ; Dallérac GM; Vatsavayai SC; Hirst MC; Murphy KP
Brain Res Bull; 2007 Apr; 72(2-3):103-7. PubMed ID: 17352933
[TBL] [Abstract][Full Text] [Related]
8. YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease.
Ghilan M; Bostrom CA; Hryciw BN; Simpson JM; Christie BR; Gil-Mohapel J
Brain Res; 2014 Sep; 1581():117-28. PubMed ID: 24949563
[TBL] [Abstract][Full Text] [Related]
9. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.
Murmu RP; Li W; Holtmaat A; Li JY
J Neurosci; 2013 Aug; 33(32):12997-3009. PubMed ID: 23926255
[TBL] [Abstract][Full Text] [Related]
10. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP
Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease.
Ransome MI; Renoir T; Hannan AJ
Neural Plast; 2012; 2012():874387. PubMed ID: 22830053
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms.
Giralt A; Saavedra A; Alberch J; Pérez-Navarro E
J Huntingtons Dis; 2012; 1(2):155-73. PubMed ID: 25063329
[TBL] [Abstract][Full Text] [Related]
13. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.
Mazarakis NK; Mo C; Renoir T; van Dellen A; Deacon R; Blakemore C; Hannan AJ
J Huntingtons Dis; 2014; 3(3):299-309. PubMed ID: 25300333
[TBL] [Abstract][Full Text] [Related]
14. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Murphy M; Hannan AJ
Neurobiol Dis; 2008 Mar; 29(3):490-504. PubMed ID: 18165017
[TBL] [Abstract][Full Text] [Related]
15. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
Murphy KP; Carter RJ; Lione LA; Mangiarini L; Mahal A; Bates GP; Dunnett SB; Morton AJ
J Neurosci; 2000 Jul; 20(13):5115-23. PubMed ID: 10864968
[TBL] [Abstract][Full Text] [Related]
16. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
[TBL] [Abstract][Full Text] [Related]
17. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington's disease.
Tyebji S; Hannan AJ
Prog Neurobiol; 2017 Jun; 153():18-45. PubMed ID: 28377290
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.
Lynch G; Kramar EA; Rex CS; Jia Y; Chappas D; Gall CM; Simmons DA
J Neurosci; 2007 Apr; 27(16):4424-34. PubMed ID: 17442827
[TBL] [Abstract][Full Text] [Related]
20. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
Spampanato J; Gu X; Yang XW; Mody I
Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
